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A Rapid Caspase-11 Response
Induced by IFNg Priming Is Independent
of Guanylate Binding Proteins
Sky W. Brubaker,1 Susan M. Brewer,1 Liliana M. Massis,1 Brooke A. Napier,2 and Denise M. Monack1,3,*
SUMMARY

In mammalian cells, inflammatory caspases detect Gram-negative bacterial invasion by binding lipopolysaccharides (LPS). Murine caspase-11 binds cytosolic LPS,
stimulates pyroptotic cell death, and drives sepsis pathogenesis. Extracellular
priming factors enhance caspase-11-dependent pyroptosis. Herein we compare
priming agents and demonstrate that IFNg priming elicits the most rapid and
amplified macrophage response to cytosolic LPS. Previous studies indicate that
IFN-induced expression of caspase-11 and guanylate binding proteins (GBPs)
are causal events explaining the effects of priming on cytosolic LPS sensing.
We demonstrate that these events cannot fully account for the increased
response triggered by IFNg treatment. Indeed, IFNg priming elicits higher pyroptosis levels in response to cytosolic LPS when macrophages stably express caspase-11. In macrophages lacking GBPs encoded on chromosome 3, IFNg priming
enhanced pyroptosis in response to cytosolic LPS as compared with other priming
agents. These results suggest an unknown regulator of caspase-11-dependent
pyroptosis exists, whose activity is upregulated by IFNg.
INTRODUCTION
The innate immune response to lipopolysaccharide (LPS) at a cellular level is compartmentalized, allowing
for distinct responses to Gram-negative pathogens based on subcellular localization (Brubaker et al., 2015).
Extracellular LPS engages Toll-like receptor 4 (TLR4) at the plasma membrane and induces the transcription
of pro-inflammatory cytokines such as IL-6, pro-IL-1b, pro-IL-18, as well as type-I interferons (IFNa/b) (Akira
and Takeda, 2004). In contrast, the response to cytosolic LPS triggers an inflammatory form of programmed
cell death termed pyroptosis by binding to murine Caspase-11 (CASP11) or either human Caspase-4 or
Caspase-5 (CASP4, CASP5) (Kayagaki et al., 2013; Hagar et al., 2013; Shi et al., 2014). These inflammatory
caspases, as well as Caspase-1 (CASP1), are cysteine proteases that control pyroptosis by enzymatically
cleaving gasdermin D (GSDMD) (Shi et al., 2015; Kayagaki et al., 2015). Following GSDMD cleavage, N-terminal ‘‘p30’’ GSDMD domain subunits (NT-GSDMD) oligomerize and form pores in the plasma membrane
(Ding et al., 2016; Liu et al., 2016; Aglietti et al., 2016). These pores result in cell membrane damage
and ultimately death. The response to cytosolic LPS is also associated with release of bioactive IL-18
and IL-1b, which requires active CASP1 for processing (Kayagaki et al., 2011). Mechanistically CASP1 is activated downstream of CASP11 through NLRP3-dependent sensing of K+ efflux that results from NT-GSDMD
pore formation (Ruhl and Broz, 2015).
Increasingly, evidence supports the idea that the macrophage response to cytosolic LPS is regulated by
extracellular stimuli. For example, members of the IFN family of cytokines influence the macrophage
response to cytosolic LPS. Several reports indicate that IFNs upregulate the expression of CASP11, which
is believed to increase sensitivity to cytosolic LPS by facilitating the chance of interaction (Rathinam et al.,
2012; Broz et al., 2012; Meunier et al., 2014). Indeed, a set of TLRs trigger the production of IFNa/b and thus
TLR ligands are commonly used to enhance the macrophage response to cytosolic LPS. Additionally IFNs
promote the expression of a set of GTPases known as the guanylate binding proteins (GBPs), which are recruited to microbe-associated membranes including endosomes, pathogen-containing vacuoles, as well
as microbial membranes (Tretina et al., 2019). At these sites, and in the context of Gram-negative bacterial
infections, murine GBPs encoded on chromosome 3 facilitate CASP11/4/5-dependent responses to LPS
(Meunier et al., 2014; Pilla et al., 2014; Finethy et al., 2015). Recent studies in human cells have further
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elucidated the role of GBPs in this process by providing evidence that a GBP signaling platform is assembled with LPS to facilitate CASP4 activation (Wandel et al., 2020; Santos et al., 2020). Both studies provide
evidence that human GBP1 is critically required for assembling a complex with LPS, GBP2, GBP3, GBP4,
and CASP4 for inflammasome activation. Thus, IFNs promote the transcriptional upregulation of factors
that enhance pyroptosis in response to LPS in the cytosol.
Despite many insights into the transcriptional control of pyroptosis regulators by these extracellular signals, the functional differences between IFNs and TLR ligands when comparing inflammasome activation
remains poorly defined. One reason for this lack of clarity derives from the fact that many studies have
examined the distinct activities of IFNs or TLR ligands individually on the effects of pyroptosis. These events
are hereafter referred to as ‘‘priming’’ events and represent activities that increase the rate or magnitude of
pyroptosis. In this study, we compared the effects of IFN or TLR4 priming on CASP11 inflammasome activation to characterize differences in how these extracellular stimuli regulate the response to cytosolic LPS.
We demonstrate that type II IFN (IFNg), as compared with IFNb or LPS, is the most potent at enhancing
CASP11-dependent pyroptosis induced by cytosolic LPS in murine macrophages. This enhancement
may be relevant during infection with Gram-negative bacteria given that IFNg production in vivo is critical
for driving CASP11-dependent protective responses against Burkholderia thailandensis (Aachoui et al.,
2015). The amplified IFNg-mediated response in macrophages is specific to CASP11 inflammasome activation as IFNg priming has no effect on NLRP3 activity. We provide evidence that, although IFNg promotes
the expression of CASP11, the priming effects of IFNg extend beyond CASP11 upregulation. Moreover,
IFNg priming significantly enhances CASP11-dependent responses compared with IFNb or LPS priming
in BMDMs lacking CASP1 or all GBPs encoded on chromosome 3, which includes the homolog of human
GBP1. Overall, we conclude that IFNg priming specifically promotes rapid CASP11-dependent pyroptosis
in response to cytosolic LPS by a process that is independent of GBPs encoded on chromosome 3 or its
ability to upregulate CASP11 expression. An unknown IFNg-inducible factor likely contributes to
CASP11 activation and pyroptosis in response to cytosolic LPS.

RESULTS
IFNg Is a Potent Priming Agent for the Response to Cytosolic LPS in Macrophages
To study inflammasome-dependent pyroptosis, researchers have historically primed macrophages with a
variety of TLR agonists, recombinant IFNs or cytokines (Latz et al., 2013). Priming is understood to transcriptionally upregulate the expression of critical inflammasome components. For example, the expression of NLRP3 and IL-1b are transcriptionally upregulated by TLR ligands or TNF, a key step for NLRP3
inflammasome activation (Bauernfeind et al., 2009, 2016). Priming for CASP11-dependent pyroptosis
can be achieved with TLR agonists, such as LPS, or recombinant IFNs, which induce the expression of
CASP11. Mechanistically, LPS upregulates CASP11 expression indirectly via TLR4-dependent TRIF
signaling and the production of type I IFNs, highlighting the importance of IFN signaling in CASP11
expression (Rathinam et al., 2012; Broz et al., 2012). IFNg, the sole type II IFN, is a well-established activator of macrophages and also primes bone marrow-derived macrophages (BMDMs) for the CASP11dependent response to cytosolic LPS(Schauvliege et al., 2002; Rathinam et al., 2012; Meunier et al.,
2014). Despite our understanding that priming is important for both NLRP3 and CASP11-dependent inflammasome activation and pyroptosis, little is known about how these priming agents differ in their ability to promote these distinct processes.
To further characterize differences between priming conditions, we set out to determine the relative abilities of
IFNs and TLR ligands to promote NLRP3- and CASP11-dependent inflammasome activation and pyroptosis.
Based on previously published priming conditions, we treated primary BMDMs for 16 h with IFNg (100 U/
mL), IFNb (100 U/mL), or LPS (10 ng/mL) and monitored NLRP3- or CASP11-dependent inflammasome activation. As expected, LPS priming significantly increased NLRP3-induced BMDM cell death (measured by release
of lactate dehydrogenase; LDH) 2 h after treatment with the classical NLRP3 activators, ATP or Nigericin (Figure 1A). IL-18 and IL-1b cytokine release, which are associated with inflammasome activation, were also significantly higher 2 h after NLRP3 activation in BMDMs primed with LPS (Figures 1B and 1C). These results are in line
with previous publications demonstrating that LPS is a potent priming agent for NLRP3 inflammasome activation. However, neither IFNg nor IFNb promoted NLRP3 inflammasome activation as determined by cell death or
cytokine release 2 h after activation (Figures 1A–1C). The kinetics of cell death monitored by the incorporation of
SYTOX Green further support the conclusion that LPS, but not IFNg or IFNb, primes BMDMs for NLRP3
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Figure 1. IFNg is a Potent Priming Agent for the Response to Cytosolic LPS in Macrophages
(A–D) WT BMDMs were primed for 16 h overnight with the following treatments: unprimed (N/A), IFNg (100 U/mL), IFNb
(100 U/mL), or LPS (10 ng/mL). NLRP3 and CASP11 inflammasome activation was triggered with ATP (5 mM), Nigericin
(10 mM), or by LPS (E. coli 0111:B4, 25 mg/mL) transfection with FuGENE HD (Fu/LPS). At 2 h following inflammasome
activation, supernatants were collected to measure release of (A) lactate dehydrogenase (LDH) for percent cell death
calculations, (B) IL-18, and/or (C) IL-1b. (D) Cell death kinetics were monitored over time following inflammasome
activation by measuring the incorporation of SYTOX Green.
(E) Cell lysates were collected from BMDMs treated for 16 h of priming as described above and separated by SDS-PAGE.
Western blot analysis was performed to determine protein expression of critical inflammasome components: NLRP3,
CASP11, GSDMD, pro-IL-18, pro-IL-1b, and the loading control ACTIN.
(F) Quantitation of CASP11 expression was compared with CASP11-induced cell death by LPS transfection (Fu/LPS). Bar
graphs in black correspond to the left axis, which represents CASP11 expression as band intensity normalized to ACTIN.
The mean percent cell death at 2 h following LPS transfection (from the three independent experiments shown in A) are
plotted in pink and correspond to the right axis.
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Figure 1. Continued
(G) WT BMDMs were primed and transfected with LPS (E. coli 0111:B4, 25 mg/mL) as described for (A–D), then
supernatants and lysates were collected at 1, 2, 3 h post transfection to monitor for the cleavage and release of
inflammasome-related proteins by SDS-PAGE and western blot. Molecular weight marker positions are shown to the left
of each blot, and arrows indicate a cleavage product. Bar graphs show the mean value +/ SEM along with individual data
points pooled from independent experiments depicted with different shapes (A–C and F). Line graphs show the mean G
SD of three technical replicates (D). Data were pooled from three (A and F) or two (B and C) independent experiments or
are representative of three (D and E) or two (G) independent experiments.
Statistical analysis performed using a two-way ANOVA and Tukey’s multiple comparisons test; **** <0.0001; *** = 0.00020.0001; * = 0.0463. See also Figure S1.

inflammasome activation (Figure 1D). Interestingly, we observed a different pattern of cell death and cytokine
release using the same priming conditions for CASP11 inflammasome activation by transfected LPS. IFNg priming significantly increased cell death and IL-18 release following LPS transfection compared with BMDMs
primed with LPS or IFNb or left unprimed (Figures 1A and 1B). However, IL-1b release following LPS transfection
was only detected in BMDMs primed with LPS (Figure 1C). Monitoring cell death at later time points demonstrates that priming with IFNb or LPS also promotes cell death in response to transfected LPS, which is in line
with previous reports (Figure 1D). However, BMDMs primed with IFNg and subsequently transfected with
LPS die at a faster rate and to a greater extent than BMDMs primed with IFNb or LPS (Figures 1A and 1D). These
data demonstrate that inflammasome complex activation is differentially regulated by the macrophage priming
agents IFNg, IFNb, and LPS. For example, NLRP3 inflammasome activation could only be promoted with LPS,
whereas all three priming agents promoted CASP11 inflammasome activation. Interestingly, these priming conditions promoted CASP11 inflammasome activation to different extents, with IFNg priming inducing the most
potent response.
Since priming is known to induce the expression of critical inflammasome components, we sought to determine how IFNg, IFNb, and LPS differentially regulate these proteins as a way to mechanistically explain inflammasome activation differences. To this end, primary BMDMs were treated for 16 h with IFNg, IFNb, or
LPS as described above and cell lysates were separated by SDS-PAGE for western blot. As expected, LPS
priming increased the expression of NLRP3 compared with priming with IFNg or IFNb (Figure 1E). Therefore, the difference between IFNg, IFNb, and LPS priming on NLRP3 inflammasome activation can in part
be attributed to the ability or inability of a priming agent to induce the expression of NLRP3. Furthermore,
the expression of pro-IL-1b is highly induced by LPS priming, demonstrating that release of IL-1b is not a
good marker of inflammasome activation when BMDMs are primed with IFNg or IFNb (Figures 1C and 1E).
Although the expression of pro-IL-18 is increased by priming with IFNb or LPS, expression levels between
priming conditions are more similar making the release of IL-18 a better marker of inflammasome activation
when comparing conditions of priming (Figures 1B and 1E, S1A, and S1C). As expected, the expression of
CASP11 was induced by IFNg, IFNb, and LPS priming (Figure 1E). The two CASP11 proteins detected by
western blot represent the full-length protein and an N-terminally truncated isoform generated by alternative translation similar to isoforms generated by the transcript encoding MAVS (data not shown) (Brubaker
et al., 2014; Kang et al., 2000). In contrast to the induction of CASP11 by priming, GSDMD expression remained constant as described previously (Kayagaki et al., 2019). By comparing CASP11 expression with cell
death 2 h following LPS transfection (Fu/LPS), we found that the percentage of cell death correlated with
the level of CASP11 expression for IFNg-primed BMDMs (Figure 1F). However, the percentage of cell death
at 2 h following LPS transfection was barely elevated for IFNb- or LPS-primed BMDMs despite higher levels
of CASP11 expression (Figure 1F). These data suggest that other factors in addition to CASP11 regulate the
response to cytosolic LPS. We also conducted a dose titration of priming agents to compare CASP11
expression and cell death at 3 h following LPS transfection (Figures S1A–S1D). LPS induced high levels
of CASP11 expression; however, LPS-induced cell death by transfection was much lower compared with
similar levels of CASP11 priming by IFNg (Figures S1A and S1B). In contrast, priming with IFNb required
much higher concentrations compared with IFNg to induce similar levels of CASP11 expression and to
induce equivalent levels of LPS-induced cell death (Figures S1C and S1D).
Further supporting the notion that IFNg is the most potent promoter of CASP11 inflammasome activation, we found that increased cell death by IFNg priming correlated with GSDMD cleavage. Cleaved
NT-GSDMD accumulated more rapidly in cell lysates from IFNg-primed BMDMs transfected with LPS
compared with IFNb or LPS primed BMDMs (Figure 1G). In addition, the release of CASP11, NTGSDMD, HMGB1, cleaved CASP1, and cleaved IL-18 was higher in supernatants from BMDMs primed
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with IFNg compared with IFNb or LPS (Figure 1G). Release of cleaved IL-1b into the supernatants was
highest in LPS-primed BMDMs; however, this can be explained by the dramatic difference in pro-IL-1b
expression between priming agents (Figures 1E and 1G). Collectively, these data demonstrate that
IFNg is a potent priming agent for the response to cytosolic LPS in BMDMs.

IFNg Priming Specifically Promotes CASP11 Inflammasome Activation
Previous publications have demonstrated that the murine BMDM inflammasome response to cytosolic LPS requires CASP11 activity and GSDMD. Once cleaved by CASP11, the NT-GSDMD fragment generates pores in
the plasma membrane causing a K+ efflux that triggers NLRP3-dependent CASP1 inflammasome activation
(Ruhl and Broz, 2015). Thus, the response to cytosolic LPS is associated with downstream CASP1 activity, which
contributes to cell death as well as the release of bioactive IL-18 and IL-1b (Kayagaki et al., 2011; Ruhl and Broz,
2015). Since IFNg priming did not promote NLRP3 inflammasome activation with classic NLRP3 agonists (Figures 1A–1D), we speculated that the effect of IFNg may specifically promote CASP11 inflammasome activation
rather than promoting downstream NLRP3/CASP1 inflammasome activation. To test this hypothesis, we
compared CASP11 inflammasome activation by transfected LPS in WT, Casp1 / , and Casp11 / BMDMs.
In line with our previous results, IFNg priming significantly increased WT BMDM cell death (measured by release
of LDH) and release of IL-18 3 h after LPS transfection compared with unprimed, IFNb-primed, or LPS primed WT
BMDMs (Figures 2A and 2B). The release of IL-1b was only detected in WT BMDMs primed with LPS (Figure 2C).
However, as described earlier, IFNg and IFNb do not induce the expression of pro-IL-1b, making release of IL-1b
an unreliable marker of inflammasome activation when comparing these priming conditions (Figures 1E and 2E).
As expected, cell death and IL-18 release following LPS transfection was completely dependent on CASP11
regardless of the priming condition used (Figures 2A and 2B). Furthermore, IL-18 and IL-1b release were
completely dependent on CASP1, which is consistent with its role in cleaving these cytokines and promoting
their secretion (Kayagaki et al., 2011; Ruhl and Broz, 2015). There was a significant decrease in the level of
cell death following LPS transfection when comparing WT with Casp1 / BMDMs primed with IFNg (Figure 2A).
This result is consistent with a role for NLRP3-dependent sensing of K+ efflux contributing to the cytosolic LPS
response observed previously (Ruhl and Broz, 2015). However, there were significant differences in the cell death
response to cytosolic LPS when CASP1-deficient BMDMs were primed with IFNg, IFNb, or LPS (Figure 2A).
Similar to WT BMDMs, IFNg priming in Casp1 / BMDMs promoted a faster rate and greater magnitude of
cell death compared with priming with IFNb or LPS (Figures 2A and 2D). Importantly, the levels of CASP11
expression in CASP1-deficient BMDMs primed with IFNg and LPS were similar, suggesting that a factor other
than CASP11 controls the differential response seen between IFNg and LPS priming (Figure 2E). Collectively,
these data support the conclusion that IFNg priming specifically promotes CASP11 activation in response to
transfected LPS independent of NLRP3 and CASP1.
We considered whether IFNg priming might specifically promote delivery of LPS to the cytosol during
transfection. Using a FITC-labeled LPS conjugate, we found that IFNg priming did not increase the amount
of FITC-LPS recovered from transfected BMDMs (Figure S2A). Therefore, IFNg does not simply promote
ligand binding by increasing the efficiency of LPS transfection.
NT-GSDMD pore formation occurs downstream of GSDMD cleavage but upstream of NLRP3 inflammasome
activation (Kayagaki et al., 2015). Comparing the kinetics of GSDMD cleavage between differentially primed
BMDMs (Figure 1G) suggested to us that IFNg promotes a mechanism upstream of NT-GSDMD rather than
pore formation itself. To directly test if IFNg treatment regulates NT-GSDMD pore formation, we generated
a cell line in Gsdmd-CRISPR/Cas9 KO RAW cells that expresses the NT-GSDMD fragment under a Doxycycline-inducible promoter. These NT-GSDMD inducible cells were either primed with IFNg or left unprimed
for 16 h, then treated with increasing concentrations of Doxycycline to induce the expression of NT-GSDMD
and monitored for cell death (Figure S2B). IFNg had no effect on cell death following Doxycycline treatment,
demonstrating that NT-GSDMD pore formation proceeds independently of IFNg priming. These data suggest
that IFNg promotes CASP11-dependent pyroptosis upstream of NT-GSDMD pore formation.

Priming Promotes Cell Death in Response to Cytosolic LPS Independently of CASP11
Expression
We observed that the kinetics and extent of pyroptosis in WT BMDMs in response to cytosolic LPS did not
always correlate directly with the level of CASP11 expression following treatment with IFNg, IFNb, or LPS
(Figures 1A, 1B, 1D–1F, and S1A–S1D). These findings suggest that another factor or factors dependent on
priming may promote the response to cytosolic LPS independently of CASP11 expression. To test this
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Figure 2. IFNg Priming Specifically Promotes CASP11 Inflammasome Activation
(A–D) WT, Casp1 / , and Casp11 / BMDMs were primed for 16 h overnight with the following treatments: unprimed
(N/A), IFNg (100 U/mL), IFNb (100 U/mL), or LPS (10 ng/mL). CASP11 inflammasome activation was triggered by LPS
(E. coli 0111:B4, 25ug/mL) transfection with FuGENE HD. At 3 h following inflammasome activation, supernatants were
collected to measure release of (A) LDH for percent cell death calculations, (B) IL-18, and/or (C) IL-1b. (D) Cell death
kinetics were monitored over time following inflammasome activation by measuring the incorporation of SYTOX Green.
(E) Cell lysates were collected from WT, Casp1 / , or Casp11 / BMDMs treated for 16 h of priming as described above
and separated by SDS-PAGE. Western blot analysis was performed to determine protein expression of critical
inflammasome components: CASP11, CASP1, GSDMD, pro-IL-18, pro-IL-1b, and the loading control ACTIN. Molecular
weight marker positions are shown to the left of each blot. Bar graphs show the mean value +/ SEM along with individual
data points pooled from independent experiments depicted with different shapes (A–C). Line graphs show the mean
value +/ SEM from pooled independent experiments with technical triplicates (D). Data were pooled from three (A and
D) or two (B and C) independent experiments or are representative of three independent experiments (E).
Statistical analysis performed using a two-way ANOVA and Tukey’s multiple comparisons test; **** <0.0001. See also Figure S2.

hypothesis directly, we set out to generate a cell line that constitutively expresses CASP11 from a retroviral
expression vector to uncouple the expression of CASP11 from priming. To this end, we chose to use RAW
264.7 cells, which are more amenable to genetic manipulations. Importantly, this immortalized cell line behaves similarly to WT BMDMs in our assays despite requiring a higher concentration of IFNb to induce comparable levels of CASP11 expression (Figures S3A–S3E). IFNg priming of RAW 264.7 cells promoted faster
kinetics and higher levels of cell death in response to cytosolic LPS delivered by transfection or with the
Cholera Toxin B (CTB) subunit as compared with unprimed, IFNb-primed, or LPS-primed cells (Figures
S3B and S3C). CTB-mediated delivery of LPS to activate CASP11 has been described previously (Kayagaki
et al., 2013; Hagar et al., 2013). In addition, similar to observations in WT BMDMs (Figure S2A), IFNg did not
appear to increase the efficiency of LPS transfection into RAW 264.7 as measured with a FITC-labeled LPS
conjugate capable of inducing CASP11-dependent inflammasome activation (Figures S3D and S3E). Thus,
the immortalized RAW 264.7 cell line is a suitable background to uncouple the expression of CASP11 from
priming and test if priming can still influence the response to cytosolic LPS.
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Figure 3. Priming Promotes Cell Death in Response to Cytosolic LPS Independently of CASP11 Expression
A constitutive CASP11-expressing cell line was generated by transducing a CASP11 expression vector into
Casp1,Casp11-CRISPR/Cas9 DKO RAW cells (Casp1/11 DKO).
(A) Cell lysates were collected from WT, Casp1/11 DKO, and the constitutive cell line (Casp1/11 DKO + Casp11) and
analyzed by western blot to determine CASP1 and CASP11 expression. WT and Casp1/11 DKO were treated with IFNg
(100 U/mL) for 16 h.
(B) The constitutive CASP11-expressing cell line was primed for 16 h overnight with the following treatments; unprimed
(N/A), IFNg (100 U/mL), IFNb (1,000 U/mL), or LPS (10 ng/mL). Lysates were collected to determine the effects of priming
on CASP11 expression by western blot.
(C and D) The constitutive CASP11-expressing cell line was primed as described above and CASP11 inflammasome
activation was triggered by LPS (E. coli 0111:B4, 50 mg/mL) transfection with FuGENE HD. (C) At 4 and 8 h following
inflammasome activation, supernatants were collected to measure release of LDH for percent cell death calculations. (D)
Alternatively, supernatants and lysates were collected 3 h post transfection to monitor for the cleavage and release of
inflammasome-related proteins by SDS-PAGE and western blot. Molecular weight marker positions are shown to the left
of each blot, and arrows indicate a cleavage product. Bar graphs show the mean value +/ SEM along with individual data
points pooled from independent experiments depicted with different shapes (C). Data were pooled from two (C)
independent experiments or are representative of three (A and B) or two (D) independent experiments.
Statistical analysis performed using a two-way ANOVA and Tukey’s multiple comparisons test; **** <0.0001. See also
Figure S3.

To generate the CASP11 constitutive cell line, we transduced Casp1,Casp11-CRISPR/Cas9 DKO RAW macrophages with a construct that constitutively drives CASP11 expression and selected for a clone with stable
expression similar to that observed in WT RAW 264.7 cells primed with IFNg (Figure 3A). There were minimal changes to CASP11 and GSDMD expression when this cell line was primed with IFNg, IFNb, or LPS
(Figure 3B). Despite this, each of the priming agents promoted cell death following LPS transfection as
observed by the release of LDH and GSDMD cleavage (Figures 3C and 3D). In support of our hypothesis
that IFNg is the most potent promoter of CASP11 inflammasome activation, IFNg priming resulted in significantly higher levels of cell death in this cell line compared with IFNb or LPS priming (Figure 3C). In addition,
higher amounts of HMGB1 were released from IFNg-primed cells compared with IFNb or LPS priming
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(Figure 3D). Similar results were obtained when cytosolic LPS was delivered with CTB (Figures S3F and
S3G). Specifically, IFNg priming promoted higher levels of cell death, GSDMD cleavage, and release of
HMGB1 (Figures S3F and S3G). Because this constitutive CASP11-expressing cell line is CASP1 deficient,
these data further support our conclusion that IFNg specifically promotes CASP11-dependent cell death
independently of CASP1. By genetically uncoupling the ability of priming agents to induce CASP11 expression, these data demonstrate that IFNg promotes rapid pyroptosis in response to cytosolic LPS through an
unknown mechanism that is separate from its ability to induce CASP11 expression.

IFNg Receptor Signaling Enhances but Is Not Required for CASP11 Inflammasome Activation
Our data demonstrate that IFNg priming enhances CASP11 inflammasome activation in response to cytosolic LPS. To identify genes required for this enhanced response to cytosolic LPS, we utilized the GeCKOv2
pooled gRNA library to generate and screen a genome-wide CRISPR knockout library in the constitutive
CASP11-expressing cell line described in Figure 3 (Sanjana et al., 2014). We conducted survival screens
by activating the cell death response to cytosolic LPS with or without IFNg priming. Enrichment of gRNAs
in the surviving cell populations was determined using the MAGeCK algorithm (Li et al., 2014). Cells containing gRNAs that target the IFNg receptor-encoding genes, Ifngr1 and Ifngr2, were highly enriched with
IFNg priming compared with the unprimed condition (Figure S4). More specifically, there was no enrichment of Ifngr1 and Ifngr2 gRNA-containing cells following CASP11 inflammasome activation without
IFNg priming. These data suggest that IFNg receptor signaling is not required for CASP11 inflammasome
activation but is required for the IFNg enhanced response against cytosolic LPS.
IFNg induces a pleiotropic set of transcriptional, translational, and metabolic changes in macrophages by
binding and signaling through a heterodimer receptor complex composed of IFNgR1 and IFNgR2
(Schroder et al., 2004; Su et al., 2015). Based on our CRISPR screen results, we suspected that signaling
through this receptor complex enhances but is not absolutely critical for the response to cytosolic LPS.
To formally test this hypothesis, we compared the response to cytosolic LPS between WT and Ifngr1 /
BMDMs (Huang et al., 1993). Compared with WT BMDMs, there was a significant reduction in cell death
following LPS transfection in Ifngr1 / BMDMs primed with IFNg (Figure 4A). This result is not surprising,
given that CASP11 expression was not induced in Ifngr1 / BMDMs primed with IFNg as compared with
WT BMDMs (Figure 4B). If we primed Ifngr1 / BMDMs with IFNb or LPS, however, CASP11 expression
was induced and there was a significant increase in the cell death response to cytosolic LPS compared
with unprimed Ifngr1 / BMDMs (Figures 4A and 4B). Furthermore, there was no significant difference
in the cell death response to cytosolic LPS between WT and Ifngr1 / BMDMs when cells were primed
with IFNb or LPS (Figure 4A). These data provide evidence that IFNg receptor signaling is not critical for
the response to cytosolic LPS but rather enhances it.
Monitoring the kinetics of cell death following LPS transfection also supports the conclusion that IFNg receptor signaling is not critical for the response to cytosolic LPS. As we observed previously, WT BMDMs
primed with IFNg exhibited the most rapid cell death response to transfected LPS compared with IFNb-,
LPS-, or unprimed BMDMs (Figure 4C). The kinetics of cell death for IFNg receptor-deficient BMDMs
were similar to WT BMDMs when primed with IFNb or LPS, whereas Ifngr1 / BMDMs primed with
IFNg died at a rate similar to unprimed BMDMs. These data demonstrate that IFNg receptor signaling is
only required to promote rapid cell death in response to cytosolic LPS when BMDMs are primed with
IFNg (Figure 4C). Finally, unprimed WT and Ifngr1 / BMDMs undergo similar cell death kinetics in
response to transfected LPS compared with LPS treatment alone (Figure 4D). Thus, IFNg receptor signaling
is not required for basal responses to cytosolic LPS in the absence of priming. Collectively, our data demonstrate that IFNg receptor signaling is not critical for CASP11 activation but suggest that IFNg priming induces the expression or activation of an unknown factor that enhances the response to cytosolic LPS.

IFNg Enhancement of CASP11-Dependent Pyroptosis Requires GSDMD and Is Independent
of GSDME
Pyroptosis as an outcome of inflammasome activation has primarily been attributed to cleavage of GSDMD
by CASP11 or CASP1(Shi et al., 2015; Kayagaki et al., 2015). Following cleavage, the N-terminal fragment of
GSDMD forms pores in the plasma membrane resulting in pyroptotic cell death, and thus, BMDMs deficient for GSDMD are refractory to CASP11- or CASP1-induced pyroptosis (Shi et al., 2015; Kayagaki
et al., 2015; Ding et al., 2016; Liu et al., 2016; Aglietti et al., 2016). Recent publications have now revealed
that GSDME, a homolog of GSDMD, is cleaved by alternative cell death pathways and the GSDME
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Figure 4. IFNg Receptor Signaling Enhances but is not Required for CASP11 Inflammasome Activation
(A, C, and D) WT and Ifngr1 / BMDMs were primed for 16 h overnight with the following treatments: unprimed (N/A),
IFNg (100 U/mL), IFNb (100 U/mL), or LPS (10 ng/mL). CASP11 inflammasome activation was triggered by LPS (E. coli
0111:B4, 25 mg/mL) transfection with FuGENE HD.
(A) At 2 h following inflammasome activation, supernatants were collected to measure release of LDH for percent cell
death calculations.
(B) Cell lysates were collected from BMDMs treated for 16 h of priming as described above and separated by SDS-PAGE.
Western blot analysis was performed to determine protein expression of CASP11, GSDMD, and the loading control
ACTIN. Molecular weight marker positions are shown to the left of each blot.
(C and D) Cell death kinetics were monitored over time following inflammasome activation by measuring the
incorporation of SYTOX Green. (C) Comparisons between different priming conditions are shown for BMDMs transfected
with LPS. (D) Additionally, a comparison between unprimed WT and Ifngr1 / BMDMs treated with or without
transfection reagent are shown. Bar graphs show the mean value +/ SEM along with individual data points pooled from
independent experiments depicted with different shapes (A). Line graphs show the mean G SD of three technical
replicates (C and D). Data were pooled from two (A) independent experiments or are representative of two (B–D)
independent experiments.
Statistical analysis performed using a two-way ANOVA and Tukey’s multiple comparisons test; **** <0.0001; *** <0.002.
See also Figure S4.

N-terminal fragment similarly causes a necrotic form of rapid cell death (Rogers et al., 2017; Wang et al.,
2017; Sarhan et al., 2018; Aizawa et al., 2020). Based on these previous findings, we set out to determine
whether the enhanced response to cytosolic LPS induced by IFNg priming strictly requires GSDMD or
whether it may also depend on GSDME.
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Figure 5. IFNg Enhancement of CASP11-Dependent Cell Death Requires GSDMD and Is Independent of GSDME
(A and B) WT, Gsdmd / , and Gsdme / BMDMs were primed for 16 h overnight with or without IFNg (100 U/mL).
CASP11 inflammasome activation was triggered by LPS (E. coli 0111:B4, 25 mg/mL) transfection with FuGENE HD. (A) At
4 h following inflammasome activation, supernatants were collected to measure release of LDH for percent cell death
calculations. (B) Cell death kinetics were monitored over time following inflammasome activation by measuring the
incorporation of SYTOX Green.
(C) Cell lysates were collected from WT, Gsdmd / , or Gsdme / BMDMs treated for 16 h of priming as described
above and separated by SDS-PAGE. Western blot analysis was performed to determine protein expression of CASP11,
GSDMD, GSDME, and the loading control ACTIN. Molecular weight marker positions are shown to the left of each blot.
Bar graphs show the mean value +/ SEM along with individual data points pooled from independent experiments
depicted with different shapes (A). Line graphs show the mean G SEM from pooled independent experiments (B). Data
were pooled from two (A and B) independent experiments or are representative of two independent experiments (C).
Statistical analysis performed using a two-way ANOVA and Tukey’s multiple comparisons test; **** <0.0001. See also
Figure S5.

We began by comparing the cell death response to cytosolic LPS in WT, Gsdmd / , and Gsdme /
BMDMs primed with or without IFNg. As expected, there were significantly lower levels of cell death at
4 h following LPS transfection in IFNg-primed BMDMs derived from Gsdmd / mice (Figure 5A). Monitoring the kinetics of cell death by SYTOX Green incorporation over time also demonstrated the absolute
requirement of GSDMD for the response to IFNg priming and cytosolic LPS (Figure 5B). Although GSDMD
was absolutely required, we observed no difference in cell death between WT and Gsdme / BMDMs
primed with IFNg and transfected with LPS (Figures 5A and 5B). Importantly, CASP11 expression was similarly induced across all genotypes, eliminating the possibility that GSDMD and GSDME might control
CASP11 expression in response to IFNg (Figure 5C). These data provide evidence that the enhanced
CASP11-dependent response to cytosolic LPS induced by IFNg strictly requires GSDMD and is independent of GSDME.
As mentioned above, GSDME can be cleaved by alternative cell death pathways. For example, TAK1 inhibition in conjunction with TLR4 activation triggers an alternative CASP8/CASP3 cell death pathway in
BMDMs that results in both GSDMD and GSDME cleavage (Sarhan et al., 2018; Orning et al., 2018).
NLRP3 inflammasome activation in the absence of CASP1 activity provides another example in which macrophages switch to an alternative cell death pathway that triggers CASP8/CASP3 cleavage and relies on
GSDMD as well as GSDME cleavage for cell death (Sagulenko et al., 2013; Schneider et al., 2017; Aizawa
et al., 2020). Based on our results from experiments using Gsdme / BMDMs (Figures 5A–5C), we did
not expect IFNg priming to promote cell death through the CASP8/CASP3/GSDME alternative cell death
pathway. In support of this hypothesis, we found no evidence of CASP8, CASP3, or GSDME cleavage under
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Figure 6. GBPs Encoded on Chromosome 3 Do Not Fully Account for Enhanced CASP11-Dependent Cell Death
Triggered by IFNg Priming
(A and B) WT, Gbpchr3 / , and Casp11 / BMDMs were primed for 16 h overnight with or without IFNg (100U/mL).
CASP11 inflammasome activation was triggered by treating cells with OMVs (E. coli DH5a), LPS (E. coli 0111:B4,
25 mg/mL) transfection with FuGENE HD, or LPS (E. coli 0111:B4, 25 mg/mL) mixed with CTB (Cholera Toxin B Subunit,
20 mg/mL). (A) At the indicated time points following inflammasome activation, supernatants were collected to
measure release of LDH for percent cell death calculations. (B) Cell lysates were collected from WT, Gbpchr3 / ,
and Casp11 / BMDMs treated with or without IFNg as described above and separated by SDS-PAGE.
Western blot analysis was performed to determine protein expression of GBP2, CASP11, GSDMD, and the
loading control ACTIN.
(C–F) WT, Gbpchr3 / , and Casp11 / BMDMs were primed for 16 h overnight with the following treatments: unprimed
(N/A), IFNg (100 U/mL), IFNb (100 U/mL), or LPS (10 ng/mL). CASP11 inflammasome activation was triggered by LPS
transfection (C and E) or with CTB and LPS (D and F) as described above. Cell death was determined following
inflammasome activation by collecting supernatants at 3 h to monitor LDH release (C and D), or cell death kinetics were
monitored over time by measuring the incorporation of SYTOX Green (E and F).
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Figure 6. Continued
(G) Cell lysates were collected from WT and Gbpchr3 / BMDMs treated for 16 h of priming as described above and
separated by SDS-PAGE. Western blot analysis was performed to determine protein expression of GBP2, CASP11,
GSDMD, pro-IL-18, and the loading control ACTIN.
(H) WT and Gbpchr3 / BMDMs were primed and transfected with LPS as described above. Supernatants and lysates
were collected from untransfected, 1, 2, or 3 h post-transfection to monitor for the cleavage and release of inflammasomerelated proteins by SDS-PAGE and western blot. Molecular weight marker positions are shown to the left of each blot, and
arrows indicate a cleavage product. Bar graphs show the mean value +/ SEM along with individual data points pooled
from independent experiments depicted with different shapes (A, C, and D). Line graphs show the mean value +/ SEM
from pooled independent experiments with technical replicates (E and F). Data were pooled from four (A - Fu/LPS and
CTB/LPS) or two (A - OMV, C, D, E, F) independent experiments or are representative of two (B and G) or one (H)
independent experiment.
Statistical analysis performed using a two-way ANOVA and Tukey’s multiple comparisons test; **** <0.0001; *** for (C) =
0.0005; * for (A) = 0.0453; * for (D) = 0.0294. See also Figure S6.

IFNg priming conditions in our constitutively expressing CASP11 RAW 264.7 cell line or in WT BMDMs (Figures S5A and S5B). TAK1 inhibition by 5z7 or CASP1-deficient BMDMs were used as positive controls in
these experiments to observe CASP8, CASP3, GSDME cleavage. In conditions where CASP8 and CASP3
were cleaved, we also detected the smaller p20 fragment of GSDMD, a product of CASP3 activity (Sarhan
et al., 2018; Orning et al., 2018; Chen et al., 2019). Since IFNg priming does not directly promote NLRP3
inflammasome activation (Figure 1), cleavage of CASP8, CASP3, and GSDME in Casp1 / BMDMs primed
with IFNg and transfected with LPS is likely the result of downstream K+ efflux-mediated NLRP3 activation,
which switches to an alternative necrotic cell death pathway in the absence of CASP1(Ruhl and Broz, 2015;
Schneider et al., 2017; Aizawa et al., 2020).
Collectively, these data suggest that the enhanced CASP11-dependent response to cytosolic LPS that is
triggered by IFNg priming strictly requires GSDMD for pyroptosis. This enhanced cell death response to
IFNg priming and LPS transfection did not rely on GSDME and we found no evidence of GSDME cleavage
that would suggest it plays a role in the process. Furthermore, the enhanced response to cytosolic LPS triggered by IFNg priming cannot be attributed to cleavage of CASP8 or CASP3, which constitute an alternative cell death pathway under certain conditions. Although it is possible that IFNg priming enhances the
response to cytosolic LPS through a cell death pathway that has yet to be determined, our findings are
consistent with the idea that IFNg specifically primes and enhances the CASP11-GSDMD-pyroptosis
pathway.

GBPs Encoded on Chromosome 3 Do Not Fully Account for Enhanced CASP11-Dependent
Cell Death Triggered by IFNg Priming
The guanylate-binding proteins (GBPs) have gained attention for their role during inflammasome activation
in response to bacterial infection or in response to OMVs shed by Gram-negative bacteria (Pilla et al., 2014;
Meunier et al., 2014; Finethy et al., 2015, 2017; Man et al., 2016; Santos et al., 2018; Cerqueira et al., 2018;
Tang et al., 2018; Fisch et al., 2019; Gu et al., 2019). These proteins are highly upregulated in response to
IFNg and are recruited to pathogen containing vacuoles and/or directly to bacteria during infection (Tretina et al., 2019). A subset of GBPs are required for CASP11 inflammasome activation in murine-derived
BMDMs and are thought to play a role in facilitating CASP11-LPS interaction (Santos et al., 2018; Cerqueira
et al., 2018). Recent evidence in human cells demonstrates that GBP1 binds to LPS and assembles a
signaling platform with several other GBPs for CASP4 activation (Wandel et al., 2020; Santos et al.,
2020). Based on these findings, we speculated that inducible GBPs could account for the increased level
of CASP11-dependent pyroptosis we observe with IFNg priming (Figures 1, 2, and 3).
There are eleven highly conserved GBPs encoded in mice. Six of these are tandemly encoded on chromosome 3 and were collectively deleted to generate Gbpchr3 /- mice (Yamamoto et al., 2012). These mice have
been used previously to demonstrate the importance of GBPs for inflammasome activation during bacterial
infection (Pilla et al., 2014; Meunier et al., 2014, 2015; Finethy et al., 2015; Man et al., 2016). Importantly, the
closest homolog of human GBP1 is encoded within the chromosome 3 locus. Given the importance of human GBP1 in activating CASP4 (Wandel et al., 2020; Santos et al., 2020), this may help to explain defects in
CASP11 inflammasome activation during bacterial infection using Gbpchr3 /- BMDMs (Pilla et al., 2014;
Meunier et al., 2014; Finethy et al., 2015). In line with previous reports, IFNg primed Gbpchr3 /- BMDMs
displayed a partial defect in the cell death response to cytosolic LPS as triggered by treatment with
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E. coli-derived OMVs, LPS transfection, or LPS complexed with CTB (Figure 6A and S6A) (Pilla et al., 2014;
Finethy et al., 2017; Santos et al., 2018; Cerqueira et al., 2018; Tang et al., 2018; Gu et al., 2019). BMDMs
derived from Gbpchr3 /- mice failed to upregulate Gbp2 when treated with IFNg but importantly express
equivalent levels of CASP11 as compared with WT controls (Figure 6B). These data demonstrate that the
interferon inducible GBPs encoded on chromosome 3 are partially required for CASP11 inflammasome
activation when BMDMs are primed with IFNg. However, it remained to be determined whether the
enhanced IFNg response to cytosolic LPS can be fully attributed to the function of these GBPs encoded
on chromosome 3.
An important aspect of our current study lies in the comparison between different priming agents demonstrating that IFNg priming elicits the most rapid and amplified macrophage response to cytosolic LPS. For
example, in testing Casp1 / BMDMs we observed a partial defect in the cell death response following
IFNg priming and LPS transfection (Figures 2A and 2D). However, we also compared the cell death
response in Casp1 / BMDMs using different priming agents and found significant differences between
IFNg priming compared with IFNb or LPS. Together these data demonstrate that CASP1 is involved in the
response to cytosolic LPS (likely downstream of K+ efflux as discussed above) but that CASP1 is not
required for the differences observed between priming agents. Based on these results, we reasoned it
would also be important to compare the response to cytosolic LPS using different priming agents in
Gbpchr3 /- BMDMs to determine if the GBPs encoded on chromosome 3 are required for the enhanced
cell death response observed with IFNg priming.
When comparing the effect of different priming agents, we found significant differences in the cell death
response to cytosolic LPS in Gbpchr3 /- BMDMs. In line with our previous results, IFNg priming significantly
increased CASP11-dependent cell death in WT BMDMs transfected with LPS or treated with CTB/LPS (Figures 6C and 6D). Similarly, IFNg priming promoted significantly higher levels of CASP11-dependent cell
death in Gbpchr3 /- BMDMs compared with priming with IFNb or LPS (Figures 6C and 6D). IFNg priming
also promotes a more rapid CASP11-dependent response in Gbpchr3 /- BMDMs compared with other
priming agents (Figures 6E and 6F). These data suggest that GBPs encoded on chromosome 3 are not
required for the differential outcome observed between priming conditions. In line with results from WT
and Casp1 / BMDMs, the greatest difference in priming responses for CASP11 inflammasome activation
in Gbpchr3 /- BMDMs lies between IFNg and LPS priming. Importantly, LPS priming induces equivalent
levels of CASP11 expression, if not more, than IFNg priming in Gbpchr3 /- BMDMs (Figure 6G). Thus, the
defect in CASP11-dependent responses using LPS priming conditions cannot be attributed to defects in
CASP11 expression.
To confirm that IFNg priming promotes a more rapid and robust CASP11-dependent response independently of GBPs encoded on chromosome 3, we compared GSDMD cleavage over time and the release
of cytokines from WT and Gbpchr3 /- BMDMs under different priming conditions. For the GSDMD cleavage
experiment, we chose to focus on the difference between IFNg and LPS priming based on the greater
phenotypic range between these conditions. Following LPS transfection, the N-terminal cleaved fragment
of GSDMD accumulated more rapidly in WT BMDM lysates primed with IFNg compared with LPS priming,
which confirms our previous results (Figures 6H and 1G). In support of our hypothesis, cleaved NT-GSDMD
also accumulated more rapidly in the lysates of Gbpchr3 /- BMDMs primed with IFNg compared with LPS
priming. Furthermore, the release of cleaved NT-GSDMD and HMGB1 into the supernatant was higher in
Gbpchr3 /- BMDMs primed with IFNg compared with LPS priming (Figure 6H). An increased release of
cleaved IL-18 from IFNg-primed Gbpchr3 /- BMDMs was more subtle but could be confirmed by an ELISA
on supernatants collected at 3 h following CASP11 activation (Figures 6H and S6B).
Our data provide support to a growing body of research that demonstrate an important role for GBPs encoded on chromosome 3 in the response to cytosolic LPS by CASP11. However, we show that the enhanced
CASP11-dependent response triggered by IFNg priming cannot solely be attributed to the function of
GBPs encoded on chromosome 3. Interestingly, GBP1 is encoded within the chromosome 3 locus, which
is of interest because its human homolog was recently shown to play an important role in assembling a
GBP signaling platform with CASP4 and LPS (Wandel et al., 2020; Santos et al., 2020). Because Gbpchr3 deficiency does not account for differences in CASP11-dependent responses between IFNg- and LPS-priming,
our data suggest that an unknown factor(s) controls the differential response seen between these priming
conditions.
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DISCUSSION
By comparing CASP11-dependent responses under different priming conditions, our study reveals
specificity between these external cues that dictate inflammasome activation outcome. A key finding
from our research is the demonstration that IFNg priming promotes the most rapid and robust
CASP11-dependent response compared with IFNb or LPS priming. Our results suggest that IFNg induces the activity of an unidentified CASP11 regulator that enhances pyroptosis in response to cytosolic LPS. This finding justifies a renewed search for unknown regulators of cytosolic LPS sensing, as
the known regulators of this process cannot fully explain the priming effects of IFNg. Several lines
of evidence support this conclusion. First, with the exception of complete CASP11 deficiency, we
did not observe a direct correlation between the extent of CASP11 expression and the responsiveness
of cells to different priming agents. Indeed, IFNg retained the ability to prime and increase pyroptosis
levels in a cell line constitutively expressing CASP11. Furthermore, we provide evidence that GBPs encoded on chromosome 3 do not fully account for the enhanced effects of IFNg priming compared with
IFNb or LPS priming. We note, however, that we verify a role for GBPs encoded on chromosome 3 in
CASP11 inflammasome activation as demonstrated by a partial defect in Gbpchr3 /- BMDMs response
to cytosolic LPS (Pilla et al., 2014; Finethy et al., 2017; Santos et al., 2018; Cerqueira et al., 2018; Tang
et al., 2018; Gu et al., 2019). Our results do not exclude the possibility that other interferon inducible
GBPs (outside the chromosome 3 locus) are responsible for the enhancement of CASP11 responses
driven by IFNg priming. There is no evidence to date, however, indicating a role in CASP11 function
for these GBPs encoded outside chromosome 3. In conclusion, our data demonstrate that the
observed IFNg-dependent increased response to transfected LPS must be controlled by a mechanism
independent of its ability to control the expression of CASP11 or GBPs encoded on chromosome 3.
Based on these findings we propose that IFNg priming induces the activity of an unknown CASP11
regulator(s).
Often with little regard to the priming step, the field of inflammasome research has primarily focused on the
activation step and downstream effector functions, such as pyroptosis and cytokine release. Our data support previous research that demonstrates that priming agents differentially dictate inflammasome
outcome (Figure 1) (Bauernfeind et al., 2009, 2016). To understand the biological relevance of these variable outcomes, future studies will likely require the use of in vivo models of infection. For example, Aachoui
and colleagues provide compelling evidence that IFNg produced by NK and T cells in vivo is critically
important to prime CASP11 and protect against infection using the model pathogen Burkholderia thailandensis (Aachoui et al., 2013, 2015; Kovacs et al., 2020). However, in vivo CASP11 responses can also be deleterious, causing higher rates of mortality in models of septic shock (Kayagaki et al., 2013; Hagar et al., 2013).
Based on these diametrically opposed outcomes, the activation of CASP11 in vivo must be tightly regulated to provide protection when needed while simultaneously limiting collateral damage. Therefore,
we speculate that the CASP11 response may have evolved a sensitivity to IFNg priming as a mechanism
for gauging the level of infectious threat in vivo.
Transcription of Casp11 is undoubtedly an important factor in tightly regulating the effects of CASP11,
and yet our understanding of the promoter elements and transcription factors controlling expression is
somewhat limited. Previous work demonstrates that CASP11 induced by LPS priming requires the nuclear
factor kB (NF-kB), the C/EBP homologous protein (CHOP), and Poly (ADP-ribose) polymerase-1 (PARP-1)
(Schauvliege et al., 2002; Endo et al., 2006; Yoo et al., 2011). The only identified transcription factor
known to control CASP11 expression following IFNg priming is STAT1 (Schauvliege et al., 2002). Future
research that expands our understanding of the transcription factors regulating CASP11 expression under different priming conditions may help to clarify the functional differences we observe between these
conditions.
The effects of IFNg treatment on macrophages are pleiotropic but generally understood to drive antimicrobial responses (Schroder et al., 2004). Hundreds of genes are transcriptionally induced, rates of
mRNA translation are shifted, and changes to metabolism highlight just some of the changes that occur
following IFNg treatment (Su et al., 2015). Thus, the phenotype described in this manuscript could be regulated transcriptionally, translationally, or enzymatically. The pleiotropic effects of IFNg treatment are akin
to our understanding of IFN-driven mechanisms that are broadly antiviral. For example, hundreds of interferon stimulated genes (ISGs) contribute to antiviral mechanisms that protect the host, yet our understanding of their functional relevance individually remains limited (Schoggins, 2019).
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As mentioned previously, a strength of our study is derived from the comparison between different priming
agents on inflammasome outcome. The greatest difference in response was observed between IFNg and
LPS priming, which could not be explained by differential CASP11 or GBP expression. Our interpretation of
these results led us to hypothesize that IFNg priming may induce the expression or activity of an enhancer(s) that promotes CASP11 inflammasome activation. Alternatively, LPS may induce the expression
or activity of a negative regulator(s) that inhibits CASP11 inflammasome activation. This alternative hypothesis would fit with most of the data that we present in this manuscript. However, experiments utilizing the
constitutive CASP11 expressing cell line suggest this may not be the case. Specifically, LPS priming in this
cell line promoted higher levels of cell death following CASP11 activation compared with unprimed cells
(Figure 3C). If LPS priming induced the expression or activity of an inhibitor, we might expect to see lower
levels of CASP11-induced cell death in this cell line as compared with unprimed cells.
Future studies are required to test these hypotheses and may lead to the identification of our proposed
IFNg-inducible enhancer(s) of CASP11 activation or an LPS-inducible inhibitor(s) of the same response.
We speculate that unknown CASP11 regulators that either enhance or inhibit the response to cytosolic
LPS may also play a role in CASP4/CASP5-dependent responses in human cells. Furthermore, the identification of unknown enhancers or inhibitors to these responses may aid in drug development for treating
bacterial infections or sepsis.

Limitations of the Study
Several publications have highlighted inflammasome activation differences between mouse and human
systems. Our study was limited to experiments in mouse macrophages, which provided us with the specific
advantage of utilizing primary cells (BMDMs) for the majority of our experiments. Therefore, it will be of
importance to compare different priming agents in the context of human CASP4/CASP5 inflammasome
activation. Given that CASP4 is constitutively expressed in many cell types, inducible regulators of the
response to cytosolic LPS may be even more important in this context. Additionally, it was beyond the
scope of this manuscript to compare priming conditions in other cell types. It will be interesting to determine if IFNg priming enhances CASP11 inflammasome activation in other cell types or if this response is
specific to macrophages.
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Figure S1. IFN𝜸 is a More Potent Priming Agent for CASP11-dependent inflammasome
activation. Related to Figure 1
WT BMDMs were primed as indicated for 16hrs overnight in technical triplicate and cell lysates were
collected to determine the expression levels of CASP11 and pro-IL-18 by Western blot (A,C). In
parallel, WT BMDMs were primed as indicated for CASP11 activation by LPS (E. coli 0111:B4, 25ug/
mL) transfection with FugeneHD (Fu/LPS). At 3hrs following inflammasome activation, supernatants
were collected to measure release of LDH for percent cell death calculations. Quantitations of
CASP11 expression (from A,C) are compared against Fu/LPS-induced cell death (B,D). Bar graphs in
black correspond to the left axis, which represents CASP11 expression as band intensity normalized
to ACTIN. Percent cell death at 3 hours following LPS transfection is plotted in grey and corresponds
to the right axis. Bar graphs depict the mean +/- SD using triplicates for each condition. Molecular
weight marker positions are shown to the left of each blot. Data are representative of 4 (A,B) or 3
(C,D) independent experiments.
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Figure S2. IFN𝜸 Priming Does not Promote Transfection-dependent Delivery of LPS or NTGSDMD Pore Formation. Related to Figure 2
(A) Transfection-dependent delivery of LPS was determined using a FITC-labelled LPS conjugate.
WT BMDMs were primed for 16hrs overnight with the following treatments; unprimed (N/A), IFN𝜸
(100U/mL), or LPS (10ng/mL). The BMDMs were then transfected with a FITC-conjugated LPS
(E. coli 0111:B4, 25ug/mL) using FugeneHD. Following transfection, cell lysates were collected,
and the relative fluorescence intensity of lysates was measured. (B) A Doxycycline-inducible NTGSDMD cell line was generated in Gsdmd-CRISPR/Cas9 KO RAW cells. Prior to Dox-induced
expression of NT-GSDMD, cells were treated with or without IFN𝛾 (100U/mL) for 16hrs. Following
Dox-induced expression of NT-GSDMD, cell death was determined by measuring release of LDH
in the supernatant. Bar graphs show the mean value +/- SD of triplicates (A,B). Data are
representative of 2 independent experiments (A,B).
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Figure S3. IFN𝜸 Priming Enhances CASP11-dependent Cell Death in RAW 264.7
Independently of CASP11 Expression. Related to Figure 3
(A) WT RAW 264.7 cells were left unprimed or treated with IFN𝜸, IFN𝜷, or LPS at the indicated
concentrations for 16hrs and cell lysates were collected to determine the expression of CASP11
by Western blot. (B-C) WT RAW 264.7 cells were primed for 16hrs overnight with the following
treatments: unprimed (N/A), IFN𝜸 (100U/mL), IFN𝜷 (1,000U/mL), or LPS (10ng/mL). Cells were
treated with LPS (E. coli 0111:B4, 25ug/mL), FugeneHD (0.5%), LPS and FugeneHD, or LPS with
CTB (Cholera Toxin B Subunit, 20ug/mL). At 4hrs (B) and 8hrs (C) following inflammasome
activation, supernatants were collected to measure release of LDH for percent cell death
calculations. (D) WT RAW 264.7 cells were left unprimed or treated with IFN𝜸 (100U/mL) for 16hrs
and CASP11 inflammasome activation was triggered by FITC-conjugated or standard LPS (E. coli
0111:B4, 25ug/mL) transfection using FugeneHD. Supernatants were collected to measure
release of LDH for percent cell death calculations. (E) Transfection-dependent delivery of LPS
was determined using the FITC-labeled LPS conjugate. WT RAW 264.7 cells were primed with or
without IFN𝜸 (100U/mL) for 16hrs and FITC-LPS was transfected with FugeneHD. Following
transfection, cell lysates were collected, and the relative fluorescence intensity of lysates was
measured. (F-G) The constitutive CASP11-expressing cell line was primed for 16hrs overnight
with the following treatments: unprimed (N/A), IFN𝜸 (100U/mL), IFN𝜷 (1,000U/mL), or LPS (10ng/
mL). CASP11 inflammasome activation was triggered with a mixture of LPS (E. coli 0111:B4,
50ug/mL) and CTB (20ug/mL). (F) At 4 and 8hrs following inflammasome activation, supernatants
were collected to measure release of LDH for percent cell death calculations. (G) Alternatively,
supernatants and lysates were collected 6hrs post-transfection to monitor for the cleavage and
release of inflammasome-related proteins by SDS-PAGE and Western blot. Molecular weight
marker positions are shown to the left of each blot, and arrows indicate a cleavage product. Bar
graphs (B-E) show the mean value +/- SD of technical triplicates and are representative of at least
2 independent experiments. Bar graphs (F) show the mean value +/- SEM along with individual
data points pooled from 2 independent experiments depicted with different shapes. Western blots
(A,G) are representative of 2 independent experiments. Statistical analysis performed using a
Two-way ANOVA and Tukey’s multiple comparisons test; **** < 0.0001
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Figure S4. Genome-wide CRISPR KO Survival Screen Identifies Genes Encoding IFN𝜸
Receptor. Related to Figure 4
We generated a genome-wide CRISPR knockout library in the constitutive CASP11 expressing cells
(described in Figure 3) and selected for surviving cell populations following treatment with or without
IFN𝜸 priming and transfected with LPS. Each axis depicts the enrichment score for gRNAs present in
the surviving population calculated using MAGeCK and an arbitrary selection cutoff was made at a
negative log RRA enrichment score of 7. Cell populations with gRNAs targeting Ifngr1 and Ifngr2
(highlighted in red) were only selected following Casp11 activation with IFN𝜸 priming (y-axis)
compared with an unprimed selection (x-axis).
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Figure S5. IFN𝜸 Enhancement of CASP11-dependent Cell Death is not Associated with
GSDME Cleavage. Related to Figure 5
(A) Constitutive CASP11-expressing RAW cells (see Figure 3) were primed +/- IFN𝛾 for 16hrs and
CASP11 activation was triggered by LPS (E. coli 0111:B4, 25ug/mL) transfection with FugeneHD.
Following transfection (7hrs) cell lysates and supernatants were collected and pooled to
determine Caspase and Gasdermin cleavage by Western blot. As a positive control for CASP8,
CASP3, and GSDME cleavage, cells were treated with the TAK1 inhibitor 5z7. (B) WT and
Casp1-/- BMDMs were treated with the indicated priming agents for 16hrs and transfected with
LPS (E. coli 0111:B4, 25ug/mL). Following transfection, cell lysates were collected at 3hrs and
analyzed by Western blot to determine Caspase and Gasdermin cleavage. Molecular weight
marker positions are shown to the left of each blot, and arrows indicate a cleavage product. Data
represent results from single experiments (A-B).
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Figure S6. IFN-Inducible GBPs do not Fully Account for Enhanced CASP11-dependent Cell
Death Triggered by IFN𝜸 Priming. Related to Figure 6
(A) WT, Gbpchr3-/-, and Casp11-/- BMDMs were primed for 16hrs overnight with IFN𝜸 (100U/mL) and
CASP11 inflammasome activation was triggered by treating cells with OMVs (E. coli DH5α). Cell
death kinetics were monitored over time by measuring the incorporation of SYTOX Green. (B)
Gbpchr3-/- BMDMs were primed for 16hrs overnight with the following treatments: unprimed (N/A), IFN𝜸
(100U/mL), IFN𝜷 (100U/mL), LPS (10ng/mL). CASP11 inflammasome activation was triggered by
LPS (E. coli 0111:B4, 25ug/mL) transfection with FugeneHD, or LPS (E. coli 0111:B4, 25ug/mL) mixed
with CTB (Cholera Toxin B Subunit, 20ug/mL). At 3hrs following inflammasome activation,
supernatants were collected to measure release of IL-18. Line graph shows the mean value +/- SEM
pooled from 2 independent experiments with technical replicates (A). Bar graph shows the mean
value +/- SD of samples in triplicate from one experiment (B).

1

Transparent Methods:

2

Experimental Models

3

Cell lines and primary cell cultures:

4

Primary BMDMs were differentiated from flushed femurs as described previously

5

(Broz and Monack 2013). All animal care and the bone marrow isolation procedures

6

used in this study for differentiating BMDMs were approved and are in accordance with

7

the guidelines set out by Stanford University’s Administrative Panel on Laboratory

8

Animal Care (APLAC). Briefly 6-14 week old mice were euthanized and following bone

9

marrow, isolation cells were cultured in differentiation media: Dulbecco’s Modified Eagle

10

Media (DMEM) containing L-Glutamine 4mM, D-Glucose 25mM, Sodium Pyruvate 1mM

11

(ThermoFisher catalogue #11995073) supplemented with 10% Fetal Bovine Serum

12

(FBS) and 20% conditioned media from MCSF-producing 3T3 cells (provided by Anita

13

Sil UCSF). Differentiation was conducted over 6 days in non-“TC treated” culture plates,

14

BMDMs were lifted by gentle scraping in ice-cold PBS, and frozen down in cryovials at

15

1x107 cells/mL in FBS containing 10% DMSO. MCSF conditioned media from 3T3 cells

16

was generated by splitting a confluent flask of MCSF-producing 3T3 cells 1:10 in DMEM

17

containing L-Glutamine 4mM, D-Glucose 25mM, Sodium Pyruvate 1mM (ThermoFisher

18

catalogue #11995073) supplemented with 10% FBS. Supernatants were collected on

19

day four and the media was replenished for a second collection on day seven. MCSF

20

conditioned media from day four and seven were pooled, filter sterilized (0.2 µm filter

21

flask), and stored at -80℃. Both male and female mice were used for BMDM

22

differentiation. We have not observed inflammasome activation differences in vitro

23

between BMDMs isolated from male or female mice. WT C57BL/6NJ (Stock No.

24

005304) and Ifngr1-/- (Stock No. 003288) mice were acquired from Jackson Labs,

25

femurs and/or bone marrow from knockout mice were provided by Vishva Dixit

26

(Casp11-/-, Casp1-/-, Gsdmd-/-, and Gsdme-/-), Petr Broz and Igor Brodsky (Gbpchr3-/-).

27

RAW 264.7 macrophages are an Abelson murine leukemia virus transformed cell

28

line derived from male mice and were obtained from ATCC (TIB-71). RAW cells were

29

cultured in DMEM containing L-Glutamine 4mM, D-Glucose 25mM, Sodium Pyruvate

30

1mM (ThermoFisher catalogue #11995073) supplemented with 10% FBS.

31
32

Method Details:

33

Macrophage treatments:

34

Macrophages were seeded into 96-well (40,000 cells/well) or 6-well (1x106

35

cells/well) plates with macrophage media: DMEM, containing L-Glutamine 4mM, D-

36

Glucose 25mM, Sodium Pyruvate 1mM (ThermoFisher catalogue #11995073)

37

supplemented with 10% Fetal Bovine Serum (FBS) and 10% conditioned media from

38

MCSF-producing 3T3 cells (see above). Once macrophages adhered to the plate, cells

39

were primed (16hr) with the indicated priming agents by adding a 1:1 volume of a 2x

40

working stock diluted in bone marrow macrophage media. In our hands, transfection

41

efficiency is improved with the use of Opti-MEM media and LDH assays are more

42

robust with media that does not contain Phenol red. Therefore, all inflammasome

43

activation assays were carried out in Phenol red-free Opti-MEM (Gibco #11058021 and

44

referred to as Opti-MEM throughout) to match the optimized conditions for LPS

45

transfection. Prior to transfection (LPS) or treatment (Nigericin, ATP, CTB/LPS, OMV),

46

macrophage media in the plate was removed and replaced with Opti-MEM. For LPS

47

transfection in BMDMs and WT RAW 264.7 macrophages, LPS (E. coli 0111:B4;

48

Invivogen LPS-EB VacciGrade Cat #vac-3pelps; 20-25ug/mL final concentration) and

49

FuGENE HD (0.5-0.6% final concentration) were complexed in Opti-MEM by briefly

50

vortexing and allowing the solution to incubate for 15-30min at room temperature. The

51

LPS/FuGENE HD complex was then overlayed in each well containing Opti-MEM. For

52

transfection in Casp1,Casp11-DKO +Casp11 RAW cells, the same amounts of LPS and

53

FuGENE HD were used, however the final volume of Opti-MEM was reduced by half to

54

increase transfection efficiency. For NLRP3 inflammasome activation, ATP (5mM final

55

concentration) or Nigericin (10uM final concentration) were prepared in Opti-MEM and

56

added to macrophages in Opti-MEM. For CTB/LPS treatments, LPS (20-25ug/mL final

57

concentration) and CTB (List Biological Laboratories #104; 20ug/mL final concentration)

58

were mixed in Opti-MEM by pipetting up and down and allowed to incubate for 15-

59

30min at room temperature. The CTB/LPS complex was then overlayed on

60

macrophages in wells containing Opti-MEM. For OMV treatments, E. coli derived OMVs

61

(10uL/well 96well) resuspended in PBS were added to BMDMs in Opti-MEM (see more

62

on OMV isolation below). As a positive control to activate CASP8/CASP3/Gsdme, cells

63

were treated with the TAK1 inhibitor (5z7) as described previously (Sarhan et al).

64

Briefly, 5z7 (125nM) with or without LPS (10ng/mL) in serum-free media was added to

65

cells for 5hr. Proteins in the supernatant were precipitated with TCA and combined with

66

cell lysates to determine CASP8/CASP3/Gsdme activation by Western blot(Broz and

67

Monack, 2013). To quantify the amount of LPS delivered to macrophages, 1x106 cells

68

were transfected with a FITC-labelled LPS conjugate following the procedure described

69

above. At the timepoint indicated, the media in each well was removed, cells were

70

washed twice with 4mL of PBS, lysates were collected in 300uL of RIPA buffer by gently

71

scraping, and the relative fluorescence intensity for each sample was measured with a

72

fluorometric plate reader.

73
74
75

Cell Death assays:
Cell death assays were conducted in 96-well format with BMDM or RAW cells

76

plated at 40,000 cells per well. Media was collected at the indicated timepoints and the

77

relative amount of LDH was determined using the CytoTox (Promega Cat# G1780)

78

assay following manufacturer instructions. Alternatively, SYTOX Green (ThermoFisher

79

Cat# S7020; 20nM) was included in Opti-MEM media added prior to treatment for

80

inflammasome activation. Following treatment for inflammasome activation, SYTOX

81

positive cells were enumerated using the IncuCyte S3 Live Cell Analysis Imaging

82

System. Triton X-100 (0.05% final concentration) was added to a set of control wells

83

with corresponding priming conditions to generate a total cell count and to calculate

84

percent cell death (% cell death = ((experimental count)/(count from total lysis)) x 100).

85
86
87
88

Protein analysis by Western blot:
Macrophages were plated in 6-well format at 1x106 cells per well. Cell lysates
were collected by removing the media in each well, washing with PBS, and lysing in a

89

low volume (50uL/well) of RIPA buffer containing protease inhibitors (Roche cOmplete

90

inhibitor cocktail). Protein concentrations were determined by Bradford assay (Pierce

91

Cat# 23236) according to manufacturer instructions and equal concentrations were

92

loaded for separation by standard SDS-PAGE. For experiments characterizing released

93

protein into the supernatant, a TCA precipitation protocol was used as previously

94

described(Broz and Monack, 2013) and equal fractions were loaded for SDS-PAGE. For

95

a complete list of the antibodies used for Western Blot in this publication, please refer to

96

the Key Resource Table.

97
98

Measurement of cytokine release by ELISA:

99

BMDM inflammasome activation for determining cytokine release were

100

conducted in triplicate within a 96-well format and were plated at 40,000 cells per well

101

as described above in the Cell Death assays section. Following inflammasome

102

activation supernatants were collected at the indicated timepoints and stored at -20ºC

103

for future processing. The amount of IL-18 or IL-1! present in the supernatants was

104

determined with commercially available ELISA kits by following manufacturer

105

instructions (Invitrogen: IL-18 - Cat# BMS618-3TEN, IL-1! - Cat# 88-7013-88).

106
107
108

Cell Lines Generated for this Manuscript:
RAW 264.7 KO cell lines (Casp1/11 DKO, Gsdmd KO) were generated as

109

previously described(Napier et al., 2016) and gRNAs are listed in the Key Resource

110

Table. The cell line reconstituted with constitutive CASP11 expression was generated

111

on the Casp1/11 DKO background with VSV pseudotyped retroviral constructs

112

generated in 293T cells. The cDNA encoding CASP11 was isolated from BMDMs

113

stimulated for 4hrs with LPS (100ng/mL) and cloned into pMSCV-IRES-GFP with

114

XhoI/NotI. Transduced cells were isolated by FACS based on GFP expression and

115

clonal populations were isolated. Untagged mouse NT-GSDMD PCR-amplified from

116

Flag-GSDMD was Gibson cloned (NEB) into the pLenti CMVTRE3G Puro DEST

117

inducible expression system using the EcoRV site. The cloned construct was introduced

118

into Gsdmd-CRISPR/Cas9 KO RAW cells stably expressing the reverse tetracycline

119

repressor-VP16 transactivator fusion protein pLenti CMV rtTA3G Blast using lentiviral

120

delivery. Stable transductants were selected with puromycin and dilution plating was

121

used to isolate the Gsdmd-CRISPR/Cas9 KO RAW Tet-On-NT-GSDMD clonal cell line.

122
123
124

Genome-wide CRISPR screen:
Our genome-wide CRISPR screen was conducted in the cell line that was

125

created to constitutively express CASP11 (See above). Cells were stably transduced

126

with lentiCas9-Blast (Addgene plasmid #52962) and selected with blasticidin to

127

generate cells constitutively expressing Cas9. Lentiviral production of the Mouse

128

CRISPR Knockout Pooled gRNA Library(Sanjana et al., 2014) (GeCKO V2; Addgene

129

Cat# 1000000053) was generated by co-transfecting 150 million 293FT cells with a

130

mixture of the plasmid library, ∆VPR, VSV-G, pAdVAntage packaging plasmids and

131

FugeneHD. Lentiviral-containing supernatants were pooled from the total 293FT cell

132

populations on day two and three following transfection, passed through a 0.45uM filter,

133

and stored at 4ºC. This pooled lentiviral gRNA library was used to transduce a total of

134

400 million constitutive CASP11-,Cas9-expressing cells at a MOI of 0.3 along with

135

protamine sulfate (1ug/mL). Three days following transduction, cells containing the

136

lentiviral gRNA constructs were selected with a five-day course of puromycin (5ug/mL).

137

Each screen was conducted with a starting population of >100 million cells of the pooled

138

gRNA library population to ensure sufficient knockout diversity by having an estimated

139

>500-fold coverage of each gRNA in the library. For each screen two rounds of

140

selection were conducted consisting of: 1) +/- IFN" priming 2) LPS transfection to

141

activate CASP11 inflammasome 3) a recovery period. Briefly, cells were treated +/-

142

IFN" (100 U/mL) for 16hrs in DMEM supplemented with 10%FBS and then the media

143

was replaced with Opti-MEM just prior to LPS transfection. To trigger CASP11

144

inflammasome activation, LPS (E. coli 0111:B4, InvivoGen) was complexed with

145

FuGENE HD and transfected into the knockout library. Following transfection, Opti-

146

MEM media containing LPS and FuGENE HD were removed and replaced with fresh

147

DMEM 10% FBS once a substantial level of cell death was observed by eye. Cells

148

surviving the CASP11 activation were allowed to expand prior to a second round of

149

selection or prior to collection for isolating genomic DNA. An untreated starting

150

population of the mutagenized library was used as the unselected reference for each

151

screen. Total genomic DNA was isolated from the surviving cell populations as well as

152

from the untreated starting population using QIAamp DNA MiniKits (Qiagen). Two

153

rounds of PCR were used to amplify the gRNA sequences from each population and

154

append barcodes for next-generation sequencing by MiSeq (Illumina). Finally, the

155

previously described MAGeCK algorithm was used to analyze our sequencing results

156

and generate enrichment scores for each gRNA(Li et al., 2014).

157
158
159

OMV isolation:
E. coli DH5α was grown for 8 hours in LB broth at 200 rpm at 37°C. This starter

160

culture was then back-diluted 1:1000 into 200 ml LB and grown shaking at 200 rpm

161

overnight at 37°C. Bacteria were removed by pelleting at 5000 xg for 15 minutes, and

162

the supernatant was passed through a 0.2 μm filter. OMVs were isolated by centrifuging

163

the filtered supernatant in thick-wall polycarbonate tubes (Beckman Coulter Catalog No.

164

355631) in a Type 70 Ti rotor in an Optima L-90K ultracentrifuge (Beckman Coulter) at

165

149,000 xg at 4°C for 3 hours. Following centrifugation, the supernatant was removed

166

and the resulting OMV pellet was resuspended in cell culture-grade 1x PBS pH 7.4

167

(final concentration = 440x concentrated from culture broth). The resuspended OMVs

168

were then passed through a 0.2 μm filter and stored at -80°C. This process was

169

repeated to generate three batches of OMVs. Prior to addition to mammalian cells, the

170

three batches were combined in a ratio of 1:1:1.

171
172
173

Quantification and Statistical Analysis:
Statistical calculations were conducted using GraphPad Prism software program.

174

Two-way ANOVA statistical tests were conducted with multiple comparisons as

175

indicated in each figure legend.
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KEY RESOURCES TABLE
REAGENT or RESOURCE
Antibodies
Mouse monoclonal anti-beta-Actin

SOURCE

IDENTIFIER

Sigma-Aldrich

Rabbit polyclonal anti-Caspase1 p10

Rat monoclonal anti-Caspase11 (clone 17D9)

Santa Cruz
Biotechnology
Cell Signaling
Technology
Cell Signaling
Technology
Sigma-Aldrich

Rabbit polyclonal anti-GBP2

Proteintech

Rabbit monoclonal anti-GSDMD

Abcam

Rabbit monoclonal anti-GSDME

Abcam

Rabbit monoclonal anti-HMGB1

Abcam

Goat polyclonal anti-IL-1!

R&D Systems

Rabbit monoclonal anti-IL-18

Abcam

Cat# A1978,
RRID:AB_476692
Cat# sc-514,
RRID:AB_2068895
Cat# 9661,
RRID:AB_2341188
Cat# 8592,
RRID:AB_10891784
Cat# C1354,
RRID:AB_258736
Cat# 11854-1-AP,
RRID:AB_2109336
Cat# ab209845,
RRID:AB_2783550
Cat# ab215191,
RRID:AB_2737000
Cat# ab79823,
RRID:AB_1603373
Cat# AF-401-NA
RRID:AB_416684
Cat# ab207323

Mouse monoclonal anti-NLRP3

AdipoGen

Cat# AG-20B-0014,
RRID:AB_2490202

InvivoGen

Cat# vac-3pelps

List Biological Labs

Cat# 104

ThermoFisher
Scientific
BioLegend
Promega
ThermoFisher
Scientific
ThermoFisher
Scientific
InvivoGen
InvivoGen
Sigma-Aldrich

Cat# PMC4031

Promega
Invitrogen
Invitrogen

Cat# G1780
Cat# 88-7013-88
Cat# BMS618-3TEN

ATCC

Cat# TIB-71

Rabbit polyclonal anti-Cleaved Caspase3
Rabbit monoclonal anti-Cleaved Caspase8

Biological Samples
LPS VacciGrade Lipopolysaccharide from E. coli
0111:B4
Cholera Toxin B Subunit in Low Salt
Chemicals, Peptides, and Recombinant Proteins
Recombinant IFN" Mouse Protein
Recombinant IFN!1 Mouse Protein
FuGENE HD transfection reagent
SYTOX Green Nucleic Acid Stain
Opti-MEM, no phenol red
Nigericin
ATP
(5Z)-7-Oxozeaenol (5z7)
Critical Commercial Assays
CytoTox 96 Non-Radioactive Cytotoxicity Assay
IL-1! Mouse Uncoated ELISA Kit
Il-18 Mouse ELISA Kit
Experimental Models: Cell Lines
RAW 264.7

Cat# 581302
Cat# E2311
Cat# S7020
Cat# 11058021
Cat# tlrl-nig
Cat# tlrl-atpl
Cat# 499610

Constitutive CASP11 expressing cell line:
Casp1,Casp11 CRISPR DKO +CASP11
Experimental Models: Mouse Strains for BMDM isolation
WT C57BL/6NJ
Ifngr1-/Casp1-/Casp11-/Gsdmd-/Gsdme-/Gbpchr3-/Oligonucleotides
gRNA Casp1: TGTCTCTAAAAAAGGGCCCC
gRNA Casp11: CTGAACGCAGTGACAAGCGT
gRNA Gsdmd: TCGTGGGGATGACCTGTTTG
Primer pair to clone constitutive Casp11:
fwdAAAACTCGAGACTCTGTCAAGCTGTCTTCACGGT
revAAAAGCGGCCGCTCAGTTGCCAGGAAAGAGGTAGA
AATAT
Primer pair to clone NT-Gsdmd:
fwdCAGTGTGGTGGAATTCTGCAGATGCCACCATGCCA
TCGGCCTTTGAGAAAG
revGCGGCCGCCACTGTGCTGGATCTAATCTGACAGGA
GACTGAGCTGCTTTC
Recombinant DNA
Plasmid: MSCV-IRES-GFP

This manuscript

Jackson Labs
Jackson Labs
Gift of Vishva Dixit
Gift of Vishva Dixit
Gift of Vishva Dixit
Gift of Vishva Dixit
Gift of Petr Broz and
Igor Brodsky

Stock No. 005304
Stock No. 003288

Napier et al 2016
Napier et al 2016
GeCKO V2 library
Sanjana et al. 2014
This manuscript

This manuscript

Addgene

Plasmid: pLenti CMVTRE3G Puro DEST

Addgene

Plasmid: pLenti CMV rtTA3G Blast

Addgene

Plasmid: Flag-Gsdmd

Addgene

Plasmid: lentiCas9-Blast

Addgene

Plasmid: Mouse CRISPR Knockout Pooled Library
(GeCKO v2)
Software and Algorithms
Prism8
MAGeCK

Addgene;
Sanjana et al. 2014
GraphPad
Li et al. 2014

Plasmid # 20672;
RRID:Addgene_206
72
Plasmid # 27565;
RRID:Addgene_264
29
Plasmid # 26429;
RRID:Addgene_264
29
Plasmid # 80950;
RRID:Addgene_809
50
Plasmid #52962;
RRID:Addgene_529
62
Cat #1000000053

